Anbio Biotechnology (NNNN) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.10M | -52.0% |
| 2024 | $2.30M | -31.4% |
| 2023 | $3.35M | -69.5% |
| 2022 | $10.98M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.10M | -52.0% |
| 2024 | $2.30M | -31.4% |
| 2023 | $3.35M | -69.5% |
| 2022 | $10.98M | — |